Immuneering Corp (IMRX) stock
IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.46−0.06 (-1.70%)
Close on Nov 17, 2026Market cap $224.08MP/E –Yield –
Immuneering market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Immuneering's market cap was $221.57M on Nov 11, 2026, against $272.40M a year earlier. Over the last 5 years it ranged from $32.63M to $347.78M, with a median of $164.65M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $221.57M | -5.3% |
| 2025 | Dec 31, 2025 | $233.99M | +260.1% |
| 2024 | Dec 31, 2024 | $64.98M | -68.1% |
| 2023 | Dec 29, 2023 | $203.53M | +59.5% |
| 2022 | Dec 30, 2022 | $127.62M | -4.7% |
| 2021 | Dec 31, 2021 | $133.97M | – |
See a number that looks wrong?